CASTLE BIOSCIENCES, INC. Deferred Income Tax Liabilities, Net
CASTLE BIOSCIENCES, INC. (CSTL) had Deferred Income Tax Liabilities, Net of $2.32 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-30
- 2026-06-30: Deferred Income Tax Liabilities, Net $2.32M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $2.33M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $2.33M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $3.24M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $2.32M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $2.33M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.33M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $3.24M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $3.13M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $837.00K 10-Q · filed 2025-05-05 |
| 2024-12-31 | $1.61M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.22M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-05 |
| 2024-03-31 | $206.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $206.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $441.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $441.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $441.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $428.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $614.00K 10-Q · filed 2022-11-02 |
| 2022-06-30 | $614.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $757.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $635.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |